Medical Weight Loss for Barre, Vermont Residents
Barre, Vermont residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Barre through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Barre Residents Choose New Hope Weight Loss
Since 2020, New Hope Weight Loss has treated more than 5,400 patients from its Costa Mesa, California clinic, and Barre, Vermont residents get that same physician-led program by telehealth. Pricing is flat and transparent, with care overseen by Dr. Anjmun Sharma, M.D., and no insurance required to start.
Barre is part of the area New Hope Weight Loss serves by telehealth. The same compounded semaglutide and tirzepatide protocols, the same flat pricing, and the same bilingual support reach Barre patients at home.
Patients across Barre and the surrounding area connect with Dr. Sharma by secure video, wherever they live in Vermont. We care for patients throughout downtown Barre and the greater Washington County area of central Vermont. Whether you are starting your first GLP-1 program or switching from a brand medication, your Barre treatment plan is built around your health history and goals.
Telehealth removes the distance between Barre and specialized care: your consultation happens wherever you are in Vermont. We accept HSA, FSA, Klarna, and Affirm, with no mandatory membership and no surprise charges for Barre patients.
GLP-1 Weight Loss Programs Available
Two GLP-1 programs for Barre
Compounded semaglutide starts at $166/month (a 90-day program is $499) and uses the same active ingredient as Wegovy® and Ozempic®, which produced 15-17% average body-weight loss in clinical trials. Compounded tirzepatide starts at $233/month · just $7.70/day and uses a dual GLP-1/GIP mechanism shown to reach up to 22.5% in trials.
Every plan begins with a $119 physician review. Medication is billed separately, and HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge.
How Telehealth Works for Barre
Step 1: Complete the 2-minute quiz or the medical intake form online.
Step 2: Dr. Sharma reviews your history by secure video, typically within 48 hours.
Step 3: If you are a candidate and telehealth-eligible, the state-licensed 503(a) pharmacy ships your compounded medication to your Barre address in cold-pack packaging. Follow-ups and dose adjustments also happen by video, no travel required.
Frequently Asked Questions, Barre
How do I get treatment from Barre?
As a Barre, Vermont patient you connect with our Costa Mesa, California clinic by telehealth. Dr. Sharma oversees your plan by secure video and compounded medication ships to your home; eligibility is confirmed during the consultation.
Can I do this without an in-person visit from Barre?
Yes, it is fully telehealth. Your review, prescription, and follow-up are remote, with medication shipped to Barre in cold-pack packaging, no lines and no drive.
How much does it cost for Barre patients?
A $119 physician review, then compounded semaglutide from $166/month or tirzepatide from $233/month (medication separate). HSA, FSA, Klarna, and Affirm are accepted, and there is never a distance surcharge.
What areas of Barre do you serve?
We serve patients from across Barre by telehealth, including downtown Barre and the greater Washington County area of central Vermont.
How does compounded medication compare on cost for Barre patients?
Compounded semaglutide from $166/month and tirzepatide from $233/month are a fraction of typical brand-name cash prices. Barre patients see flat pricing up front, and compounded semaglutide and tirzepatide are not FDA-approved or brand-identical, which Dr. Sharma reviews with you.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Barre, Vermont by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.